Skip to content
Screener

Viemed Healthcare, Inc. VMD Q1 2025 earnings

Reported May 7, 2025 · After market close

Revenue$59.1MMiss by $1.5M
EPS$0.06In line
Revenue estimate$60.6M
EPS estimate$0.06

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$80.8M
EPS estimate$0.12

Financials

Q1 2025

Income statement

See full
Revenue$59.1M+16.9%
Gross profit$33.3M+11.7%
Operating income$3.8M+74.3%
Net income$2.6M+63.8%
EPS (diluted)$0.06+50.0%

Balance sheet

See full
Cash & equivalents$10.2M+39.0%
Total debt$6.8M-29.1%
Total equity$134.8M+15.9%
Total assets$178.1M+15.0%

Cash flow

See full
Operating cash flow$2.9M+143%
CapEx$15.5M+158%
Free cash flow-$12.6M-161%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$287.72M-21.2%
Enterprise value$284.32M-22.6%
P/E23.4×-11.9×
P/S1.2×-0.6×

Profitability

See full
Gross margin58.7%-2.4pp
Operating margin8.4%+0.9pp
Net margin5.3%0.0pp

Returns & leverage

See full
Return on equity9.8%+0.2pp
Debt / equity0.1×0.0×
Current ratio1.4×+0.1×

Segments

By product

See full
Equipment and supply sales$7.5M+22.5%
Service revenues$6.5M+49.7%

FAQ

When did Viemed Healthcare, Inc. report Q1 2025 earnings?
Viemed Healthcare, Inc. (VMD) reported Q1 2025 earnings on May 7, 2025 after market close.
What were Viemed Healthcare, Inc.'s Q1 2025 revenue and EPS?
Viemed Healthcare, Inc. reported revenue of $59.1M and eps of $0.06 for Q1 2025.
Did Viemed Healthcare, Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $60.6M by $1.5M. EPS beat the consensus estimate of $0.06 by $0.00.
How did Viemed Healthcare, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.9% from $50.6M a year earlier and eps grew 50.0% from $0.04.
Where can I find Viemed Healthcare, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001729149-25-000086) and the 10-Q periodic report (0001729149-25-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.